Proof-of-concept study of monitoring cancer drug therapy with cerenkov luminescence imaging.

@article{Xu2012ProofofconceptSO,
  title={Proof-of-concept study of monitoring cancer drug therapy with cerenkov luminescence imaging.},
  author={Yingding Xu and Edwin Chang and Hongguang Liu and Han Jiang and Sanjiv Sam Gambhir and Zhen Cheng},
  journal={Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year={2012},
  volume={53 2},
  pages={
          312-317
        }
}
UNLABELLED Cerenkov luminescence imaging (CLI) has emerged as a less expensive, easier-to-use, and higher-throughput alternative to other nuclear imaging modalities such as PET. It is expected that CLI will find many applications in biomedical research such as cancer detection, probe development, drug screening, and therapy monitoring. In this study, we explored the possibility of using CLI to monitor drug efficacy by comparisons against PET. To assess the performance of both modalities in… CONTINUE READING
Highly Cited
This paper has 33 citations. REVIEW CITATIONS
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Optical imaging as an expansion of nuclear medicine: Cerenkov-based luminescence vs fluorescence-based luminescence

European Journal of Nuclear Medicine and Molecular Imaging • 2013
View 4 Excerpts
Highly Influenced

Gamma rays excited radioluminescence tomographic imaging

Biomedical engineering online • 2018
View 1 Excerpt